A THERAPEUTIC OR PROPHYLACTIC AGENT FOR ISCHEMIC DISEASE, GLAUCOMA, OPTIC NERVE DISEASE, RETINAL DEGENERATIVE DISEASE, ANGIOGENIC RETINAL DISEASE, CANCER, NEURODEGENERATIVE OR AUTOIMMUNE DISEASE, AND A HYPOXIA INDUCING FACTOR INHIBITOR

Number of patents in Portfolio can not be more than 2000

United States of America

SERIAL NO

16349821

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel HIF inhibitors having low cytotoxicity and suitable for ophthalmologic treatment and agents for the treatment or prevention of ischemic diseases, glaucoma, optic nerve diseases, retinal degenerative diseases, retinal degenerative diseases, angiogenic retinal diseases, cancer, neurodegenerative or autoimmune diseases are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIV KEIONot Provided

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
INOUE, Hiroyoshi Tokyo, JP 21 73
KURIHARA, Toshihide Tokyo, JP 10 3
MIWA, Yukihiro Tokyo, JP 1 0
TSUBOTA, Kazuo Tokyo, JP 47 137

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation